🇺🇸 FDA
Patent

US 6548068

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

expired A61KA61K2239/31A61K2239/38

Quick answer

US patent 6548068 (Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K39/00, A61K40/00